New gene therapy cures 1st New Yorker of sickle cell anemia

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
On this week's episode of "Watson," Watson takes a major ethical risk when he decides to treat a sickle cell patient with an ...
This episode highlights how Watson's medical format can address real-world issues in dramatically interesting ways, with a ...
Undergoing a bone marrow transplant during adolescence, but not in adulthood, may lower the risk of stroke with SCD, a mouse ...
An 18-year-old with sickle cell anemia fulfilled her wish to take a cooking class in Dallas, thanks to Make-A-Wish North ...
AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.